Literature DB >> 3142351

Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys.

V G Hemming1, G A Prince, W T London, P A Baron, R Brown, R M Chanock.   

Abstract

A human intravenous immunoglobulin preparation containing neutralizing antibodies to respiratory syncytial virus (RSV) was utilized for intratracheal and topical treatment of laboratory-induced RSV infections in owl monkeys (Aotus trivirgatus). Topically administered antibodies induced significant reductions in RSV shedding in the lower respiratory tract.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3142351      PMCID： PMC172391          DOI： 10.1128/AAC.32.8.1269

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Measurement of monoclonal antibody concentrations in hybridoma cultures: comparison of competitive inhibition and antigen capture enzyme immunoassays.

Authors:  J M Bosworth; A A Brimfield; J A Naylor; K W Hunter
Journal:  J Immunol Methods       Date:  1983-09-16       Impact factor: 2.303

2.  Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.

Authors:  V G Hemming; G A Prince; R L Horswood; W J London; B R Murphy; E E Walsh; G W Fischer; L E Weisman; P A Baron; R M Chanock
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

3.  Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.

Authors:  G A Prince; S C Suffin; D A Prevar; E Camargo; D L Sly; W T London; R M Chanock
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

4.  Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; V G Hemming; R L Horswood; P A Baron; R M Chanock
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

Authors:  G A Prince; V G Hemming; R L Horswood; R M Chanock
Journal:  Virus Res       Date:  1985-10       Impact factor: 3.303

6.  Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.

Authors:  V G Hemming; W Rodriguez; H W Kim; C D Brandt; R H Parrott; B Burch; G A Prince; P A Baron; R J Fink; G Reaman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191
  6 in total
  7 in total

1.  CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.

Authors:  H Plotnicky-Gilquin; A Robert; L Chevalet; J F Haeuw; A Beck; J Y Bonnefoy; C Brandt; C A Siegrist; T N Nguyen; U F Power
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Respiratory syncytial virus infection in children with congenital heart disease: a review.

Authors:  D E Fixler
Journal:  Pediatr Cardiol       Date:  1996 May-Jun       Impact factor: 1.655

Review 3.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 5.  Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.

Authors:  Hilal Ahmad Parray; Shivangi Shukla; Reshma Perween; Ritika Khatri; Tripti Shrivastava; Vanshika Singh; Praveenkumar Murugavelu; Shubbir Ahmed; Sweety Samal; Chandresh Sharma; Subrata Sinha; Kalpana Luthra; Rajesh Kumar
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-23       Impact factor: 5.560

6.  Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.

Authors:  Emilie Jacque; Claire Chottin; Daphné Laubreton; Michel Nogre; Cécile Ferret; Sandrine de Marcos; Linda Baptista; Carole Drajac; Philippe Mondon; Christophe De Romeuf; Marie-Anne Rameix-Welti; Jean-François Eléouët; Sami Chtourou; Sabine Riffault; Gérald Perret; Delphyne Descamps
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

Review 7.  High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.

Authors:  Xiaosheng Liu; Wei Cao; Taisheng Li
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.